Phathom Pharmaceuticals Files 8-K
Ticker: PHAT · Form: 8-K · Filed: May 1, 2025 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting
TL;DR
Phathom Pharma filed an 8-K on May 1st, reporting financial condition. Details TBD.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on May 1, 2025, reporting on its results of operations and financial condition, as well as presenting financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signifies a routine disclosure of financial and operational information by Phathom Pharmaceuticals, Inc. to the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- May 1, 2025 (date) — Date of earliest event reported
- 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The provided text indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific figures.
When was the earliest event reported in this filing?
The earliest event reported is dated May 1, 2025.
What is the principal executive office address for Phathom Pharmaceuticals, Inc.?
The principal executive offices are located at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
What is the SIC code for Phathom Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Phathom Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding Phathom Pharmaceuticals, Inc. (PHAT).